PlutusNon-dilutive vs equity: the money that doesn't cost you your company
Founders obsess over their next round and ignore the funding that costs them nothing. Here's the dilution maths most teams skip — and when non-dilutive money is the smarter first call.
"Non-dilutive" just means funding that doesn't take a slice of your company. No new shares, no board seat, no liquidation preference. Grants, R&D tax credits, innovation competitions, soft loans and venture debt all sit here. Equity funding — angels, VCs, a priced round or a SAFE — is the opposite: you trade ownership for cash.
Both have a place. The mistake is treating equity as the default and forgetting the rest exists.
The maths founders skip
Imagine you need £100k to hit your next milestone. Two ways to get it:
- Raise it. At a £1M post-money valuation, £100k costs you 10% of your company. At exit, that 10% might be worth far more than £100k — that's the real price of the cash.
- Claim it. A £100k Smart Grant or R&D credit costs you nothing in ownership. You keep the 10%. The only price is the work to apply.
Stack a year of non-dilutive funding ahead of a round and two things happen: you need to raise less, and you raise it at a higher valuation because you've de-risked the technology. Every pound of grant money is a pound you don't sell equity for — and it pushes your eventual round in your favour.
The compounding point: non-dilutive funding before a raise doesn't just save dilution today. It raises the price of every share you sell later. That's why grant-funded deep-tech teams often own more of a bigger company at exit.
When equity still wins
Non-dilutive funding is not free money with no trade-offs. Equity is the right call when:
- You need speed. A round can close in weeks; a grant can take months from application to cash.
- You need more than money. The right investor brings hiring, intros and credibility a grant never will.
- The work doesn't fit. Grants fund specific R&D and innovation. Pure go-to-market spend usually isn't eligible — that's what a round is for.
The founder-smart sequence
For most R&D-heavy startups, the order that preserves the most ownership is simple: claim everything non-dilutive you qualify for first, use it to de-risk the build, then raise equity from a stronger position for the things grants can't fund. You end up owning more of a more valuable company.
The hard part is knowing what you qualify for. Schemes change, deadlines move, and no founder has time to track every grant, credit and competition across their region. That's the gap Plutus closes.
This is general guidance, not financial advice. Valuation, dilution and tax outcomes depend on your specific situation — model your own numbers and take advice before deciding.